ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $632,000 | +6.4% | 19,665 | -1.8% | 0.00% | 0.0% |
Q2 2022 | $594,000 | +4.9% | 20,024 | +4.4% | 0.00% | 0.0% |
Q1 2022 | $566,000 | -51.1% | 19,184 | -23.7% | 0.00% | 0.0% |
Q4 2021 | $1,158,000 | +25.5% | 25,129 | -10.6% | 0.00% | 0.0% |
Q3 2021 | $923,000 | -18.5% | 28,123 | -12.9% | 0.00% | 0.0% |
Q2 2021 | $1,132,000 | -45.8% | 32,300 | -44.1% | 0.00% | -50.0% |
Q1 2021 | $2,089,000 | +102.4% | 57,793 | +128.1% | 0.00% | +100.0% |
Q1 2020 | $1,032,000 | +10.3% | 25,334 | +66.9% | 0.00% | 0.0% |
Q4 2019 | $936,000 | +50.5% | 15,183 | +78.0% | 0.00% | 0.0% |
Q3 2019 | $622,000 | +335.0% | 8,531 | +390.6% | 0.00% | – |
Q2 2019 | $143,000 | -57.4% | 1,739 | -63.5% | 0.00% | -100.0% |
Q1 2019 | $336,000 | +277.5% | 4,762 | +150.0% | 0.00% | – |
Q2 2017 | $89,000 | +11.2% | 1,905 | +17.5% | 0.00% | – |
Q1 2017 | $80,000 | +31.1% | 1,621 | +61.1% | 0.00% | – |
Q4 2016 | $61,000 | -10.3% | 1,006 | -2.4% | 0.00% | – |
Q3 2016 | $68,000 | – | 1,031 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |